Sorrento Therape OTC Stock Top Management
SRNE Stock | USD 0 0.0007 28.00% |
Sorrento Therape employs about 949 people. The company is managed by 11 executives with a total tenure of roughly 12 years, averaging almost 1.0 years of service per executive, having 86.27 employees per reported executive. Evaluation of Sorrento Therape's management performance can provide insight into the firm performance.
Henry Ji CEO Co-Founder, CEO and President and Director |
Sorrento |
Sorrento Therape Management Team Effectiveness
The company has return on total asset (ROA) of (0.4082) % which means that it has lost $0.4082 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.7892) %, meaning that it created substantial loss on money invested by shareholders. Sorrento Therape's management efficiency ratios could be used to measure how well Sorrento Therape manages its routine affairs as well as how well it operates its assets and liabilities.Sorrento Therape Workforce Comparison
Sorrento Therape is currently regarded as top stock in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 150,901. Sorrento Therape maintains roughly 949 in number of employees contributing less than 1% to equities under Health Care industry.
Sorrento Therape Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Sorrento Therape insiders, such as employees or executives, is commonly permitted as long as it does not rely on Sorrento Therape's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Sorrento Therape insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Henry Ji over a month ago Disposition of tradable shares by Henry Ji of Sorrento Therape subject to Rule 16b-3 | ||
Followwill Dorman over a month ago Acquisition by Followwill Dorman of 35000 shares of Sorrento Therape at 3.57 subject to Rule 16b-3 | ||
Henry Ji over three months ago Acquisition by Henry Ji of 10000 shares of Sorrento Therape at 4.0 subject to Rule 16b-3 |
Sorrento Therape Notable Stakeholders
A Sorrento Therape stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Sorrento Therape often face trade-offs trying to please all of them. Sorrento Therape's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Sorrento Therape's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Henry Ji | Co-Founder, CEO and President and Director | Profile | |
Mark Brunswick | VP Affairs | Profile | |
Scott Schaus | Chief Officer | Profile | |
Xiao MD | Pres ACEA | Profile | |
Robert Allen | VP RD | Profile | |
Brian Cooley | Sr BU | Profile | |
Shawn Sahebi | VP Operations | Profile | |
Alexis DVM | VP BU | Profile | |
William BSc | VP Devel | Profile | |
Elizabeth MBA | CFO VP | Profile | |
JD MD | SVP Officer | Profile |
About Sorrento Therape Management Performance
The success or failure of an entity such as Sorrento Therape often depends on how effective the management is. Sorrento Therape management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Sorrento management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Sorrento management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. The company was founded in 2006 and is based in San Diego, California. Sorrento Therpt operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 799 people.
The data published in Sorrento Therape's official financial statements typically reflect Sorrento Therape's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Sorrento Therape's quantitative information. For example, before you start analyzing numbers published by Sorrento accountants, it's essential to understand Sorrento Therape's liquidity, profitability, and earnings quality within the context of the Biotechnology space in which it operates.
Please note, the presentation of Sorrento Therape's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Sorrento Therape's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Sorrento Therape's management manipulating its earnings.
Sorrento Therape Workforce Analysis
Traditionally, organizations such as Sorrento Therape use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Sorrento Therape within its industry.Sorrento Therape Manpower Efficiency
Return on Sorrento Therape Manpower
Revenue Per Employee | 66.2K | |
Revenue Per Executive | 5.7M | |
Net Loss Per Employee | 608.8K | |
Net Loss Per Executive | 52.5M |
Complementary Tools for Sorrento OTC Stock analysis
When running Sorrento Therape's price analysis, check to measure Sorrento Therape's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sorrento Therape is operating at the current time. Most of Sorrento Therape's value examination focuses on studying past and present price action to predict the probability of Sorrento Therape's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sorrento Therape's price. Additionally, you may evaluate how the addition of Sorrento Therape to your portfolios can decrease your overall portfolio volatility.
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |